Evidence-based articles for the informed patient and caregiver — bridging the gap between PubMed abstracts and actionable knowledge. No false hope, no despair. Clear-eyed precision.
After glioblastoma radiation therapy, a new MRI finding may not always mean the tumor is back. Radiation necrosis is a serious but distinct complication — and the difference matters enormously for your next treatment decision.
A glioblastoma diagnosis turns life upside down in hours. This guide maps the critical first 30 days — from confirming the diagnosis and building your care team, to understanding surgery, molecular profiling, and what comes next — so you can move forward with clarity and purpose.
Burning, peeling, or red skin during cervical cancer radiation treatment is called radiation dermatitis. Learn why it happens, what the grades mean, and practical steps to protect and soothe your skin.
Breathlessness is one of the most common and distressing symptoms of lung cancer. Learn why it happens, what makes it worse, and the evidence-based strategies that may help you breathe easier.
Feeling completely drained after pancreatic cancer surgery is normal — and it can last longer than most people expect. Learn why this happens, what makes it worse, and practical steps that may help you rebuild your energy.
Hair loss is one of the most visible side effects of breast cancer chemotherapy. Learn why it happens, which drugs cause it, how scalp cooling may help, and practical ways to cope emotionally and physically.
A concise guide to three fast-moving GBM platforms — sonodynamic therapy, gene therapy, and MT-125 — with a focus on infiltrative disease, mechanism, and trial relevance.
How re-engineered immune cells are producing measurable tumor shrinkage in recurrent GBM — the latest trial data from Penn, Mass General, and City of Hope, and how to evaluate eligibility.
Understanding the biology of recurrence — glioma stem cells, molecular evolution, and the immunosuppressive fortress — plus treatment options, clinical trial navigation, and quality-of-life strategies.
BNCT delivers radiation at the single-cell level by loading tumor cells with boron and then firing neutrons. For patients with recurrent GBM who have already received standard radiation, it may offer a targeted re-irradiation path. Here is what the evidence actually shows.